Furthermore, MMP-2 levels were lower in the serum of COPD patients (8.74 ± 0.19 μg/mL) compared to control subjects (8.83 ± 0.20 μg/mL). This evidence concerns the gene MMP2 and chronic obstructive pulmonary disease.